Innate lymphoid cells in normal and disease: An introductory overview

Research output: Contribution to journalArticle

Abstract

Innate lymphoid cells (ILC) represent a novel group of lymphocytes that, different from T and B-lymphocytes lack recombinant activating genes (RAG-1 or RAG-2) and thus do not express rearranged antigen-specific receptors. Members of this family, i.e. NK cells, have been known since long time, while the other ILCs have been discovered only in recent years, possibly because of their predominant localization in tissues, primarily in mucosal tissues, skin and mucosa-associated lymphoid organs. ILC have been grouped in three major subsets on the basis of their phenotypic and functional features as well as of their dependency on given transcription factors (TF). Briefly, ILC-1 are dependent on T-bet TF and produce interferon (IFN)-γ. Group 2 ILC (ILC2) express GATA-3 TF and produce IL-5, IL-4 and IL-13 (Type 2) cytokines while group 3 ILC (ILC3) express RORγt TF and produce IL-17 and IL-22. ILC provide early defenses against pathogens and intervene in the repair of damaged tissues. ILC activation is mediated by cytokines (specifically acting on different ILC groups) and/or by activating receptors that are, at least in part, the same that had been previously identified in NK cells [1].

Original languageEnglish
JournalImmunology Letters
DOIs
Publication statusAccepted/In press - Jul 7 2016

Fingerprint

Lymphocytes
Natural Killer Cells
GATA3 Transcription Factor
Mucous Membrane
RAG-1 Genes
Transcription Factors
GATA Transcription Factors
Cytokines
Antigen Receptors
Interleukin-13
Interleukin-17
Interleukin-5
Interleukin-4
Interferons
B-Lymphocytes
Skin

Keywords

  • Innate lymphoid cells (ILC)
  • Innated defences
  • Natural killer (NK) cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

@article{4994c3430f3f4aa68f25d785834419ee,
title = "Innate lymphoid cells in normal and disease: An introductory overview",
abstract = "Innate lymphoid cells (ILC) represent a novel group of lymphocytes that, different from T and B-lymphocytes lack recombinant activating genes (RAG-1 or RAG-2) and thus do not express rearranged antigen-specific receptors. Members of this family, i.e. NK cells, have been known since long time, while the other ILCs have been discovered only in recent years, possibly because of their predominant localization in tissues, primarily in mucosal tissues, skin and mucosa-associated lymphoid organs. ILC have been grouped in three major subsets on the basis of their phenotypic and functional features as well as of their dependency on given transcription factors (TF). Briefly, ILC-1 are dependent on T-bet TF and produce interferon (IFN)-γ. Group 2 ILC (ILC2) express GATA-3 TF and produce IL-5, IL-4 and IL-13 (Type 2) cytokines while group 3 ILC (ILC3) express RORγt TF and produce IL-17 and IL-22. ILC provide early defenses against pathogens and intervene in the repair of damaged tissues. ILC activation is mediated by cytokines (specifically acting on different ILC groups) and/or by activating receptors that are, at least in part, the same that had been previously identified in NK cells [1].",
keywords = "Innate lymphoid cells (ILC), Innated defences, Natural killer (NK) cells",
author = "Lorenzo Moretta and Franco Locatelli",
year = "2016",
month = "7",
day = "7",
doi = "10.1016/j.imlet.2016.07.008",
language = "English",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",

}

TY - JOUR

T1 - Innate lymphoid cells in normal and disease

T2 - An introductory overview

AU - Moretta, Lorenzo

AU - Locatelli, Franco

PY - 2016/7/7

Y1 - 2016/7/7

N2 - Innate lymphoid cells (ILC) represent a novel group of lymphocytes that, different from T and B-lymphocytes lack recombinant activating genes (RAG-1 or RAG-2) and thus do not express rearranged antigen-specific receptors. Members of this family, i.e. NK cells, have been known since long time, while the other ILCs have been discovered only in recent years, possibly because of their predominant localization in tissues, primarily in mucosal tissues, skin and mucosa-associated lymphoid organs. ILC have been grouped in three major subsets on the basis of their phenotypic and functional features as well as of their dependency on given transcription factors (TF). Briefly, ILC-1 are dependent on T-bet TF and produce interferon (IFN)-γ. Group 2 ILC (ILC2) express GATA-3 TF and produce IL-5, IL-4 and IL-13 (Type 2) cytokines while group 3 ILC (ILC3) express RORγt TF and produce IL-17 and IL-22. ILC provide early defenses against pathogens and intervene in the repair of damaged tissues. ILC activation is mediated by cytokines (specifically acting on different ILC groups) and/or by activating receptors that are, at least in part, the same that had been previously identified in NK cells [1].

AB - Innate lymphoid cells (ILC) represent a novel group of lymphocytes that, different from T and B-lymphocytes lack recombinant activating genes (RAG-1 or RAG-2) and thus do not express rearranged antigen-specific receptors. Members of this family, i.e. NK cells, have been known since long time, while the other ILCs have been discovered only in recent years, possibly because of their predominant localization in tissues, primarily in mucosal tissues, skin and mucosa-associated lymphoid organs. ILC have been grouped in three major subsets on the basis of their phenotypic and functional features as well as of their dependency on given transcription factors (TF). Briefly, ILC-1 are dependent on T-bet TF and produce interferon (IFN)-γ. Group 2 ILC (ILC2) express GATA-3 TF and produce IL-5, IL-4 and IL-13 (Type 2) cytokines while group 3 ILC (ILC3) express RORγt TF and produce IL-17 and IL-22. ILC provide early defenses against pathogens and intervene in the repair of damaged tissues. ILC activation is mediated by cytokines (specifically acting on different ILC groups) and/or by activating receptors that are, at least in part, the same that had been previously identified in NK cells [1].

KW - Innate lymphoid cells (ILC)

KW - Innated defences

KW - Natural killer (NK) cells

UR - http://www.scopus.com/inward/record.url?scp=84979679248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979679248&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2016.07.008

DO - 10.1016/j.imlet.2016.07.008

M3 - Article

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

ER -